Li Q Y, Newbury-Ecob R A, Terrett J A, Wilson D I, Curtis A R, Yi C H, Gebuhr T, Bullen P J, Robson S C, Strachan T, Bonnet D, Lyonnet S, Young I D, Raeburn J A, Buckler A J, Law D J, Brook J D
Department of Genetics, University of Nottingham, Queen's Medical Centre, UK.
Nat Genet. 1997 Jan;15(1):21-9. doi: 10.1038/ng0197-21.
Holt-Oram syndrome is a developmental disorder affecting the heart and upper limb, the gene for which was mapped to chromosome 12 two years ago. We have now identified a gene for this disorder (HOS1). The gene (TBX5) is a member of the Brachyury (T) family corresponding to the mouse Tbx5 gene. We have identified six mutations, three in HOS families and three in sporadic HOS cases. Each of the mutations introduces a premature stop codon in the TBX5 gene product. Tissue in situ hybridization studies on human embryos from days 26 to 52 of gestation reveal expression of TBX5 in heart and limb, consistent with a role in human embryonic development.
Holt-Oram综合征是一种影响心脏和上肢的发育障碍,其基因在两年前被定位到12号染色体上。我们现已鉴定出导致该疾病的一个基因(HOS1)。该基因(TBX5)是与小鼠Tbx5基因相对应的Brachyury(T)家族的成员。我们已经鉴定出六个突变,其中三个在Holt-Oram综合征家族中,三个在散发性Holt-Oram综合征病例中。每个突变都在TBX5基因产物中引入了一个提前终止密码子。对妊娠26至52天的人类胚胎进行的组织原位杂交研究显示,TBX5在心脏和肢体中表达,这与它在人类胚胎发育中的作用一致。